Literature DB >> 6339534

Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man.

R Bruzzone, G Tamburrano, A Lala, M Mauceri, B Annibale, C Severi, L de Magistris, F Leonetti, G Delle Fave.   

Abstract

The effect of bombesin on insulin, pancreatic glucagon, and gut glucagon was investigated in eight healthy volunteers and two pancreatectomized patients. Bombesin, infused iv at the constant rate of 5 ng kg-1 min-1, produced a sharp and statistically significant rise in the plasma insulin concentration. The peak was reached at 5 min (26 +/- 2.17 microU/ml; P less than 0.005 vs. basal values), followed by a prolonged and statistically significant (P less than 0.05) decrease in blood glucose. Pancreatic glucagon rapidly rose to a maximal value of 80.5 +/- 7.6 pmol/liter (P less than 0.005 vs. basal values). In contrast with the prompt increase in insulin and glucagon plasma levels, the peak in gut glucagon concentration (55.8 +/- 4.6 pmol/liter; P less than 0.005 vs. basal values) was reached 30 min after bombesin infusion was discontinued. In the two pancreatectomized patients, bombesin induced an increase in gut glucagon concentrations only. The results presented indicate that bombesin acts directly on the A and B cells of the pancreas, influencing glucose homeostasis; however, more complex mechanisms seem to be involved in gut glucagon secretion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339534     DOI: 10.1210/jcem-56-4-643

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Different effects of bombesin on glucose- and tolbutamide-induced insulin release in man.

Authors:  C Scarpignato; M Gioffré; F M Gulino; B Micali
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

2.  Opposite effects of bombesin on insulin and gastrin response to food in humans.

Authors:  C Scarpignato; B Micali
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

3.  Bombesin stimulates insulin secretion by a pancreatic islet cell line.

Authors:  S L Swope; A Schonbrunn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

4.  The gastrin-releasing peptide analog bombesin preserves exocrine and endocrine pancreas morphology and function during parenteral nutrition.

Authors:  Joseph F Pierre; Joshua C Neuman; Allison L Brill; Harpreet K Brar; Mary F Thompson; Mark T Cadena; Kelsey M Connors; Rebecca A Busch; Aaron F Heneghan; Candace M Cham; Elaina K Jones; Carly R Kibbe; Dawn B Davis; Guy E Groblewski; Kenneth A Kudsk; Michelle E Kimple
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-16       Impact factor: 4.052

5.  Effects of certain metabolites on pancreatic endocrine responses to gastrin-releasing peptide in conscious calves.

Authors:  S R Bloom; A V Edwards; M A Ghatei
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

6.  Cloning and characterization of cDNAs encoding human gastrin-releasing peptide.

Authors:  E R Spindel; W W Chin; J Price; L H Rees; G M Besser; J F Habener
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates.

Authors:  Violeta Georgieva Tsonkova; Fredrik Wolfhagen Sand; Xenia Asbæk Wolf; Lars Groth Grunnet; Anna Kirstine Ringgaard; Camilla Ingvorsen; Louise Winkel; Mark Kalisz; Kevin Dalgaard; Christine Bruun; Johannes Josef Fels; Charlotte Helgstrand; Sven Hastrup; Fredrik Kryh Öberg; Erik Vernet; Michael Paolo Bastner Sandrini; Allan Christian Shaw; Carsten Jessen; Mads Grønborg; Jacob Hald; Hanni Willenbrock; Dennis Madsen; Rasmus Wernersson; Lena Hansson; Jan Nygaard Jensen; Annette Plesner; Tomas Alanentalo; Maja Borup Kjær Petersen; Anne Grapin-Botton; Christian Honoré; Jonas Ahnfelt-Rønne; Jacob Hecksher-Sørensen; Philippe Ravassard; Ole D Madsen; Claude Rescan; Thomas Frogne
Journal:  Mol Metab       Date:  2017-12-19       Impact factor: 7.422

8.  [99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.

Authors:  Panagiotis Kanellopoulos; Emmanouil Lymperis; Aikaterini Kaloudi; Marion de Jong; Eric P Krenning; Berthold A Nock; Theodosia Maina
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.